The histopathology of rheumatoid synovium suggests that an active immunological reaction is taking place. The tissue is infiltrated by large numbers of lymphocytes and macrophages which may be organised into lymphoid follicles and, rarely, germinal centres.' This is consistent with the ability of rheumatoid synovial tissue to act as an 'ectopic lymphoid organ' with both immunoglobulin synthesis2 and lymphokine release. 3 The importance of lymphocytes in maintaining the chronic inflammatory reaction is supported by the beneficial therapeutic effects of thoracic duct drainage in rheumatoid patients. 4 The stimulus for this immune reaction has yet to be identified. Infectious agents as sources of exogenous antigen have been sought for many years. However, a careful search for pathogenic organisms in the rheumatoid joint has failed to obtain conclusive evidence that such organisms are reproducibly associated with rheumatoid disease.5 An alternative hypothesis suggests that an autoantigen is expressed in rheumatoid synovial tissue, able to provoke an autoimmune reaction and promote chronic inflammation.
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The search for putative antigens in rheumatoid synovial tissue has been conducted largely with the use of the leucocyte migration inhibition test (LMT) as an indicator system. Using this assay a number of investigators have obtained different results. Rothenberger and Thiele6 reported that a crude rheumatoid synovial homogenate used as antigen in the LMT caused the specific migration inhibition ofrheumatoid leucocytes, suggesting a delayed hypersensitivity response to a component of rheumatoid synovial membrane. However, they were unable to demonstrate this effect in other experiments using a lymphocyte transformation assay. 
Results

SYNOVIAL HOMOGENATES
Crude low spin homogenates of 8 rheumatoid synovia were assayed at 3-5 concentrations in the LMT using cells from a total of 49 pairs of rheumatoid and control subjects. All the samples tested yielded inhibitory material at concentrations of protein above 200 ,ug/ml. However, none of these preparations produced specific inhibition of rheumatoid cells, being equally inhibitory for both RA and control leucocytes. This overall result is illustrated in Fig. IA, using (Fig. 1B) . were assayed in the LMT with leucocytes from 41 EDTA-mercaptoethanol extracts of synovial tissue pairs of RA and control subjects. Analysis of the caused migration inhibition when assayed in the active material from patient 13 in Table 1 (Fig. 2) . LMT. Eluates from 8 synovia were assayed at 3-5 resulted in the elution profile shown in Fig. 3 . Six protein concentrations in the LMT with leucocytes fractions from this column were concentrated and I 1 , . S . group.bmj.com on July 7, 2017 -Published by http://ard.bmj.com/ Downloaded from assayed in the LMT. As shown in Fig. 3 , the inhibitory material was found in the void-volume (fraction 1), which corresponds to a molecular weight of at least 106 daltons.
Discussion
The experiments described in this paper were performed in order to collect in a single laboratory extensive data on the interaction between rheumatoid leucocytes and rheumatoid synovial tissue extracts, and thus to clarify the role of putative synovial membrane antigens in the pathogenesis of rheumatoid arthritis. Therefore, a large number of synovia (22) were analysed and assayed in the LMT over a range of protein concentrations against a total of 157 matched pairs of rheumatoid and control leucocytes. These results constitute a much larger set of data than has been obtained in previous studies.
All 20 rheumatoid synovia yielded inhibitory material as assayed in the LMT, as did the sample from a patient with ankylosing spondylitis. In contrast, inhibitory material could not be extracted from the synovium of a patient with pigmented villonodular synovitis. This may indicate that the inhibitory material is associated with the inflammatory process. In general, this inhibitory factor showed no specificity towards rheumatoid leucocytes, being equally active against both RA and control cells in the LMT. However, occasional individual samples did yield extracts which caused 'specific' migration inhibition restricted to either rheumatoid or control leucocytes. These results may partly explain the conflicting data in the literature, since much of this was obtained from synovial preparations from single donors only.
Further studies have been carried out to characterise the inhibitory material in the synovial homogenates. Results from ultracentrifugation experiments indicated that this inhibition was associated with membrane fragments. This suggests that the inhibition of leucocyte migration may be a consequence of phagocytosis of these particles. This process is known to induce inhibition of leucocyte migration from capillary tubes.17 Such a conclusion casts doubt on the 'antigenicity' of crude synovial tissue homogenates in the LMT. However, the active factor may be solubilised from synovial membrane by extraction with EDTA-mercaptoethanol.14 Such eluates were inhibitory in the LMT at lower concentrations than were the homogenates.
The inhibitory factor, although not sedimented by high speed centrifugation was found to have a high molecular weight (greater than 106 daltons). It is possible that phagocytosis of this material was 
